Φορτώνει......
Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer
INTRODUCTION: Patients with metastatic hormone sensitive prostate cancer (mHSPC) have traditionally been treated with androgen deprivation therapy (ADT). Recently, there has been a demonstration of a survival benefit with the addition of docetaxel to ADT from three large randomized controlled trials...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Indian J Urol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Medknow Publications & Media Pvt Ltd
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5054654/ https://ncbi.nlm.nih.gov/pubmed/27843206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.191234 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|